Evidence map›Paper›PMID 22083483›Full record

ArticleAntimicrobial agents and chemotherapy2012

Yersinia pestis AcrAB-TolC in antibiotic resistance and virulence.

Ida M Lister, Connor Raftery, Joan Mecsas, Stuart B Levy

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. The tigecycline resistance mechanisms in Gram-negative bacilli.Frontiers in cellular and infection microbiology · 2024
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Temperature-Dependent Gene Expression inFrontiers in microbiology · 2018
    Article
  14. Article
  15. A TolC-Like Protein ofFrontiers in microbiology · 2016
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ida M ListerCenter of Adaptation Genetics and Drug Resistance, Tufts University School of Medicine, Boston, Massachusetts, USA.
Connor Raftery
Joan Mecsas
Stuart B Levy

Funding

The multiple antibiotic resistance (MAR)regulonR01AI056021 · NIAID · TUFTS UNIVERSITY BOSTON · PI LEVY, STUART B. · 2003 to 2017
$8.9M
NIAID NIH HHS AI 56021NIAID NIH HHS R01 AI056021
6 · The paper itself

Abstract

The efflux pump AcrAB is important in the antibiotic resistance and virulence of several pathogenic bacteria. We report that deletion of the Yersinia pestis AcrAB-TolC homolog leads to increased susceptibility to diverse substrates, including, though unlike in Escherichia coli, the aminoglycosides. Neither is the Y. pestis pump affected by the efflux pump inhibitor phenylalanine-arginine beta-naphthylamide. In mouse plague models, pump deletion does not have a significant effect on tissue colonization.

Indexed as

Drug Resistance, BacterialAnimalsAnti-Bacterial AgentsBacterial Outer Membrane ProteinsBacterial ProteinsFemaleGene DeletionHumansMembrane Transport ProteinsMiceMice, Inbred BALB CMicrobial Sensitivity TestsPlagueVirulenceYersinia pestisAnti-Bacterial AgentsBacterial Outer Membrane ProteinsBacterial ProteinsMembrane Transport Proteins

Identifiers

PMID22083483
PMCPMC3264255

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.